[Whitepaper] Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation

Changes in Drug Substance (DS) process can affect Drug Product (DP). As DS manufacturers evaluate & optimize the synthetic route, process conditions, & crystallization solvents, they must understand & track changes, & discuss them with DP formulators to anticipate challenges in formulation.

Sponsored by: